The TRAIL to viral pathogenesis: The good, the bad and the ugly

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Since the discovery of Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) in 1995, much has been learned about the protein, its receptors and signaling cascade to induce apoptosis and the regulation of its expression. However, the physiologic role or roles that TRAIL may play in vivo are still being explored. The expression of TRAIL on effector T cells and the ability of TRAIL to induce apoptosis in virally infected cells provided early clues that TRAIL may play an active role in the immune defense against viral infections. However, increasing evidence is emerging that TRAIL may have a dual function in the immune system, both as a means to kill virally infected cells and in the regulation of cytokine production. TRAIL has been implicated in the immune response to viral infections (good), and in the pathogenesis of multiple viral infections (bad). Furthermore, several viruses have evolved mechanisms to manipulate TRAIL signaling to increase viral replication (ugly). It is likely that whether TRAIL ultimately has a proviral or antiviral effect will be dependent on the specific virus and the overall cytokine milieu of the host. Knowledge of the factors that determine whether TRAIL is proviral or antiviral is important because the TRAIL system may become a target for development of novel antiviral therapies.

Original languageEnglish (US)
Pages (from-to)495-505
Number of pages11
JournalCurrent Molecular Medicine
Volume9
Issue number4
DOIs
StatePublished - 2009

Fingerprint

Virus Diseases
Antiviral Agents
Apoptosis
Viruses
Cytokines
T-cells
Immune system
Immune System
Tumor Necrosis Factor-alpha
Ligands
T-Lymphocytes
Proteins
Therapeutics

Keywords

  • Apoptosis
  • Cell mediated immunity
  • Cytomegalovirus
  • Epstein-barr virus
  • Hepatitis
  • Hepatitis Bvirus
  • Hepatitis C virus
  • Human immunodeficieny virus
  • Tumor Necrosis Factor-Related Apoptosis Inducing Ligand

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Molecular Medicine

Cite this

The TRAIL to viral pathogenesis : The good, the bad and the ugly. / Cummins, Nathan W; Badley, Andrew David.

In: Current Molecular Medicine, Vol. 9, No. 4, 2009, p. 495-505.

Research output: Contribution to journalArticle

@article{c3e98bb122314da9902e8f678d9f4c8d,
title = "The TRAIL to viral pathogenesis: The good, the bad and the ugly",
abstract = "Since the discovery of Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) in 1995, much has been learned about the protein, its receptors and signaling cascade to induce apoptosis and the regulation of its expression. However, the physiologic role or roles that TRAIL may play in vivo are still being explored. The expression of TRAIL on effector T cells and the ability of TRAIL to induce apoptosis in virally infected cells provided early clues that TRAIL may play an active role in the immune defense against viral infections. However, increasing evidence is emerging that TRAIL may have a dual function in the immune system, both as a means to kill virally infected cells and in the regulation of cytokine production. TRAIL has been implicated in the immune response to viral infections (good), and in the pathogenesis of multiple viral infections (bad). Furthermore, several viruses have evolved mechanisms to manipulate TRAIL signaling to increase viral replication (ugly). It is likely that whether TRAIL ultimately has a proviral or antiviral effect will be dependent on the specific virus and the overall cytokine milieu of the host. Knowledge of the factors that determine whether TRAIL is proviral or antiviral is important because the TRAIL system may become a target for development of novel antiviral therapies.",
keywords = "Apoptosis, Cell mediated immunity, Cytomegalovirus, Epstein-barr virus, Hepatitis, Hepatitis Bvirus, Hepatitis C virus, Human immunodeficieny virus, Tumor Necrosis Factor-Related Apoptosis Inducing Ligand",
author = "Cummins, {Nathan W} and Badley, {Andrew David}",
year = "2009",
doi = "10.2174/156652409788167078",
language = "English (US)",
volume = "9",
pages = "495--505",
journal = "Current Molecular Medicine",
issn = "1566-5240",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - The TRAIL to viral pathogenesis

T2 - The good, the bad and the ugly

AU - Cummins, Nathan W

AU - Badley, Andrew David

PY - 2009

Y1 - 2009

N2 - Since the discovery of Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) in 1995, much has been learned about the protein, its receptors and signaling cascade to induce apoptosis and the regulation of its expression. However, the physiologic role or roles that TRAIL may play in vivo are still being explored. The expression of TRAIL on effector T cells and the ability of TRAIL to induce apoptosis in virally infected cells provided early clues that TRAIL may play an active role in the immune defense against viral infections. However, increasing evidence is emerging that TRAIL may have a dual function in the immune system, both as a means to kill virally infected cells and in the regulation of cytokine production. TRAIL has been implicated in the immune response to viral infections (good), and in the pathogenesis of multiple viral infections (bad). Furthermore, several viruses have evolved mechanisms to manipulate TRAIL signaling to increase viral replication (ugly). It is likely that whether TRAIL ultimately has a proviral or antiviral effect will be dependent on the specific virus and the overall cytokine milieu of the host. Knowledge of the factors that determine whether TRAIL is proviral or antiviral is important because the TRAIL system may become a target for development of novel antiviral therapies.

AB - Since the discovery of Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) in 1995, much has been learned about the protein, its receptors and signaling cascade to induce apoptosis and the regulation of its expression. However, the physiologic role or roles that TRAIL may play in vivo are still being explored. The expression of TRAIL on effector T cells and the ability of TRAIL to induce apoptosis in virally infected cells provided early clues that TRAIL may play an active role in the immune defense against viral infections. However, increasing evidence is emerging that TRAIL may have a dual function in the immune system, both as a means to kill virally infected cells and in the regulation of cytokine production. TRAIL has been implicated in the immune response to viral infections (good), and in the pathogenesis of multiple viral infections (bad). Furthermore, several viruses have evolved mechanisms to manipulate TRAIL signaling to increase viral replication (ugly). It is likely that whether TRAIL ultimately has a proviral or antiviral effect will be dependent on the specific virus and the overall cytokine milieu of the host. Knowledge of the factors that determine whether TRAIL is proviral or antiviral is important because the TRAIL system may become a target for development of novel antiviral therapies.

KW - Apoptosis

KW - Cell mediated immunity

KW - Cytomegalovirus

KW - Epstein-barr virus

KW - Hepatitis

KW - Hepatitis Bvirus

KW - Hepatitis C virus

KW - Human immunodeficieny virus

KW - Tumor Necrosis Factor-Related Apoptosis Inducing Ligand

UR - http://www.scopus.com/inward/record.url?scp=68349136841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68349136841&partnerID=8YFLogxK

U2 - 10.2174/156652409788167078

DO - 10.2174/156652409788167078

M3 - Article

C2 - 19519406

AN - SCOPUS:68349136841

VL - 9

SP - 495

EP - 505

JO - Current Molecular Medicine

JF - Current Molecular Medicine

SN - 1566-5240

IS - 4

ER -